Ovarian hyperstimulation associated with the sole use of leuprolide for ovarian suppression.
An IVF patient who was placed on leuprolide therapy prior to ovulation induction to improve ovarian response developed moderate ovarian hyperstimulation from the sole use of the GnRH agonist. Clinicians should be aware of this possible outcome.
Yeh
J
J
Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
Barbieri
R L
RL
Ravnikar
V A
VA
D000328:Adult; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D016729:Leuprolide; D010053:Ovary / Q000187:drug effects*; D010062:Ovulation Induction / Q000379:methods*; D013268:Stimulation, Chemical
D007987:Gonadotropin-Releasing Hormone; D016729:Leuprolide